{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T21:52:50Z","timestamp":1772401970531,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.7759\/cureus.55355","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T23:58:26Z","timestamp":1709337506000},"source":"Crossref","is-referenced-by-count":1,"title":["Fatal Itching and Failing Liver: A Case Report and Literature Review of Rare, Atypical DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Abusuliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Amreia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheema","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammad J","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Abosheaishaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Hanafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. clinical perspectives. J Am Acad Dermatol. 2013, 68:693.e1-14; quiz 706-8. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (dress) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson AR","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (dress) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract. 2019, 7:633-40. 10.1016\/j.jaip.2018.08.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","unstructured":"American Osteopathic College of Dermatology. DRESS syndrome. (2022). Accessed: 2024: https:\/\/www.aocd.org\/page\/DRESS."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis P","year":"1997","unstructured":"Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997, 49:542-6. 10.1212\/wnl.49.2.542","journal-title":"Neurology"},{"key":"ref5","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary S","year":"2013","unstructured":"Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol. 2013, 6:31-7.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re H","year":"2006","unstructured":"Peyri\u00e8re H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2006, 155:422-8. 10.1111\/j.1365-2133.2006.07284.x","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(98)05418-x","article-title":"Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study","volume":"353","author":"Berthold Rzany","year":"1999","unstructured":"Berthold Rzany, Correia O, Kelly JP, et al.. Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet. 1999, 353:2190-4. 10.1016\/s0140-6736(98)05418-x","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet H","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996, 15:250-7.","journal-title":"Semin Cutan Med Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.02.2011.3898","article-title":"DRESS syndrome: a case report and literature review","volume":"2011","author":"Cardoso CS","year":"2011","unstructured":"Cardoso CS, Vieira AM, Oliveira AP. DRESS syndrome: a case report and literature review. BMJ Case Rep. 2011, 2011:10.1136\/bcr.02.2011.3898","journal-title":"BMJ Case Rep"},{"key":"ref10","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)","author":"Lee HY","year":"2023","unstructured":"Lee HY. Drug reaction with eosinophilia and systemic symptoms (DRESS). UpToDate. Post TW (ed): UpToDate, Waltham MA; 2023."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)61376-4","article-title":"Treatment of epilepsy with sodium diphenyl hydantoinate","volume":"235","author":"Coope R","year":"1940","unstructured":"Coope R, Burrows RG. Treatment of epilepsy with sodium diphenyl hydantoinate. Lancet. 1940, 235:490-2. 10.1016\/s0140-6736(00)61376-4","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::aid-cncr2820120122>3.0.co;2-y","article-title":"Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas","volume":"12","author":"Saltzstein SL","year":"1959","unstructured":"Saltzstein SL, Ackerman LV. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer. 1959, 12:164-82. 10.1002\/1097-0142(195901\/02)12:1&lt;164::aid-cncr2820120122&gt;3.0.co;2-y","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430210033005","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"155","author":"Vittorio CC","year":"1995","unstructured":"Vittorio CC. Anticonvulsant hypersensitivity syndrome. Arch Int Med. 1995, 155:2285. 10.1001\/archinte.1995.00430210033005","journal-title":"Arch Int Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890350057010","article-title":"Drug-Induced pseudolymphoma and hypersensitivity syndrome","volume":"132","author":"Callot V","year":"1996","unstructured":"Callot V. Drug-Induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol. 1996, 132:1315. 10.1001\/archderm.1996.03890350057010","journal-title":"Arch Dermatol"},{"key":"ref15","article-title":"DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome\u2014reply","volume":"134","author":"Schlienger RG","year":"1998","unstructured":"Schlienger RG, Shear NH. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome\u2014reply. Arch Dermatol. 1998, 134:876.","journal-title":"Arch Dermatol"},{"key":"ref16","article-title":"Cutaneous adverse drug reactions in hospitalised patients","volume":"51","author":"Lee D","year":"2010","unstructured":"Lee D, Yueh H, Tay L. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J. 2010, 51:767.","journal-title":"Singapore Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles SR","year":"1999","unstructured":"Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf. 1999, 21:489-501. 10.2165\/00002018-199921060-00005","journal-title":"Drug Saf"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse KC","year":"2019","unstructured":"Konvinse KC, Trubiano JA, Pavlos R, et al.. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J Allergy Clin Immunol. 2019, 144:183-92. 10.1016\/j.jaci.2019.01.045","journal-title":"J Allergy Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions","volume":"49","author":"Rieder MJ","year":"1991","unstructured":"Rieder MJ, Shear NH, Kanee A, Tang BK, Spielberg SP. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther. 1991, 49:13-7. 10.1038\/clpt.1991.3","journal-title":"Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions","volume":"136","author":"Ng CY","year":"2016","unstructured":"Ng CY, Yeh YT, Wang CW, et al.. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. J Invest Dermatol. 2016, 136:1373-81. 10.1016\/j.jid.2016.02.808","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.10.009","article-title":"Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: an immunohistochemical study","volume":"5","author":"Hansel K","year":"2017","unstructured":"Hansel K, Bellini V, Bianchi L, Brozzi J, Stingeni L. Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: an immunohistochemical study. J Allergy Clin Immunol Pract. 2017, 5:808-10. 10.1016\/j.jaip.2016.10.009","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14839","article-title":"Drug-specific CD4(+) T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome","volume":"176","author":"Ye YM","year":"2017","unstructured":"Ye YM, Hur GY, Kim SH, et al.. Drug-specific CD4(+) T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome. Br J Dermatol. 2017, 176:378-86. 10.1111\/bjd.14839","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama M","year":"2007","unstructured":"Tohyama M, Hashimoto K, Yasukawa M, et al.. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007, 157:934-40. 10.1111\/j.1365-2133.2007.08167.x","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki M","year":"2009","unstructured":"Eshki M, Allanore L, Musette P, et al.. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009, 145:67-72. 10.1001\/archderm.145.1.67","journal-title":"Arch Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen YC","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010, 146:1373-9. 10.1001\/archdermatol.2010.198","journal-title":"Arch Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1130","article-title":"Liver injury in patients with DRESS: a clinical study of 72 cases","volume":"72","author":"Lin IC","year":"2015","unstructured":"Lin IC, Yang HC, Strong C, Yang CW, Cho YT, Chen KL, Chu CY. Liver injury in patients with DRESS: a clinical study of 72 cases. J Am Acad Dermatol. 2015, 72:984-91. 10.1016\/j.jaad.2015.02.1130","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang CY","year":"2015","unstructured":"Yang CY, Chen CH, Deng ST, et al.. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med. 2015, 175:1550-7. 10.1001\/jamainternmed.2015.3536","journal-title":"JAMA Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.6698","article-title":"Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features","volume":"150","author":"Tetart F","year":"2014","unstructured":"Tetart F, Picard D, Janela B, Joly P, Musette P. Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features. JAMA Dermatol. 2014, 150:206-7. 10.1001\/jamadermatol.2013.6698","journal-title":"JAMA Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of drug-induced reactions in DRESS patients","volume":"29","author":"Picard D","year":"2015","unstructured":"Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol. 2015, 29:801-4. 10.1111\/jdv.12419","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou CC","year":"2008","unstructured":"Chiou CC, Yang LC, Hung SI, et al.. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008, 22:1044-9. 10.1111\/j.1468-3083.2008.02585.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref32","article-title":"Allopurinol","year":"2020","unstructured":"Allopurinol. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet].  National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2020."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.96351","article-title":"Allopurinol-induced DRESS syndrome","volume":"44","author":"Yaylac\u0131 S","year":"2012","unstructured":"Yaylac\u0131 S, Demir MV, Temiz T, Tamer A, Uslan MI. Allopurinol-induced DRESS syndrome. Indian J Pharmacol. 2012, 44:412-4. 10.4103\/0253-7613.96351","journal-title":"Indian J Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1984.tb03591.x","article-title":"Fulminant hepatic failure due to allopurinol","volume":"14","author":"Raper R","year":"1984","unstructured":"Raper R, Ibels L, Lauer C, Barnes P, Lunzer M. Fulminant hepatic failure due to allopurinol. Aust N Z J Med. 1984, 14:63-5. 10.1111\/j.1445-5994.1984.tb03591.x","journal-title":"Aust N Z J Med"},{"key":"ref35","article-title":"A case report on allopurinol induced dress syndrome","volume":"13","author":"Karthika S","year":"2021","unstructured":"Karthika S, Kavya S, Krishnapriya MK, Jetto DM. A case report on allopurinol induced dress syndrome. Int J Pharma Pharmaceut Sci. 2021, 13:70-1.","journal-title":"Int J Pharma Pharmaceut Sci"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201310001-00519","article-title":"Allopurinol-induced DRESS syndrome: a reversible fatality","volume":"108","author":"Chaudrey K","year":"2013","unstructured":"Chaudrey K, Muhammad K, Madhoun M, Kastens D. Allopurinol-induced DRESS syndrome: a reversible fatality. Am J Gastroenterol. 2013, 108:S153.","journal-title":"Am J Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.03094.x","article-title":"Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence","volume":"58","author":"Yang DC","year":"2010","unstructured":"Yang DC, Chang CM. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence. J Am Geriatr Soc. 2010, 58:2043-4. 10.1111\/j.1532-5415.2010.03094.x","journal-title":"J Am Geriatr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231499-fatal-itching-and-failing-liver-a-case-report-and-literature-review-of-rare-atypical-dress-drug-rash-with-eosinophilia-and-systemic-symptoms-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T23:58:33Z","timestamp":1709337513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231499-fatal-itching-and-failing-liver-a-case-report-and-literature-review-of-rare-atypical-dress-drug-rash-with-eosinophilia-and-systemic-symptoms-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.55355","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}